| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Renalytix Plc (NASDAQ: RNLX)
RNLX Technical Analysis
5
| As on 12th Nov 2024 RNLX STOCK Price closed @ 0.15 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.47 & Strong Sell for SHORT-TERM with Stoploss of 2.65 we also expect STOCK to react on Following IMPORTANT LEVELS. |
RNLXSTOCK Price
| Open | 0.14 | Change | Price | % |
| High | 0.17 | 1 Day | -0.01 | -6.25 |
| Low | 0.14 | 1 Week | -0.01 | -6.25 |
| Close | 0.15 | 1 Month | -0.13 | -46.43 |
| Volume | 94241 | 1 Year | -1.95 | -92.86 |
| 52 Week High 4.01 | 52 Week Low 0.15 | ||||
NASDAQ USA Most Active Stocks
| NCNA | 0.08 | 60.00% |
| AMRS | 0.14 | 100.00% |
| NVDA | 142.63 | 0.64% |
| HCTI | 0.01 | 0.00% |
| LCID | 2.23 | 3.72% |
| PLUG | 1.22 | 25.77% |
| TSLA | 308.58 | 4.55% |
| NVTS | 7.30 | 18.12% |
| LMDX | 0.02 | 0.00% |
| OPEN | 0.57 | -16.18% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| RNLX Daily Charts |
RNLX Intraday Charts |
Whats New @ Bazaartrend |
RNLX Free Analysis |
|
|
RNLX Important Levels Intraday
| RESISTANCE | 0.21 |
| RESISTANCE | 0.19 |
| RESISTANCE | 0.18 |
| RESISTANCE | 0.17 |
| SUPPORT | 0.13 |
| SUPPORT | 0.12 |
| SUPPORT | 0.11 |
| SUPPORT | 0.09 |
RNLX Forecast June 2025
| 4th UP Forecast | 4.35 |
| 3rd UP Forecast | 3 |
| 2nd UP Forecast | 2.17 |
| 1st UP Forecast | 1.34 |
| 1st DOWN Forecast | -1.04 |
| 2nd DOWN Forecast | -1.87 |
| 3rd DOWN Forecast | -2.7 |
| 4th DOWN Forecast | -4.05 |
RNLX Weekly Forecast
| 4th UP Forecast | 1.17 |
| 3rd UP Forecast | 0.84 |
| 2nd UP Forecast | 0.64 |
| 1st UP Forecast | 0.44 |
| 1st DOWN Forecast | -0.14 |
| 2nd DOWN Forecast | -0.34 |
| 3rd DOWN Forecast | -0.54 |
| 4th DOWN Forecast | -0.87 |
RNLX Forecast2025
| 4th UP Forecast | 7.7 |
| 3rd UP Forecast | 5.28 |
| 2nd UP Forecast | 3.78 |
| 1st UP Forecast | 2.29 |
| 1st DOWN Forecast | -1.99 |
| 2nd DOWN Forecast | -3.48 |
| 3rd DOWN Forecast | -4.98 |
| 4th DOWN Forecast | -7.4 |
Renalytix Plc ( NASDAQ USA Symbol : RNLX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
RNLX Business Profile
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record systems to generate a unique patient risk score. Its products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. Renalytix AI plc has a license agreement with Mount Sinai Health System to develop and commercialize licensed products in connection with the application of artificial intelligence for the diagnosis of kidney disease; Joslin Diabetes Center, Inc. for developing and commercializing products for diagnosing and predicting kidney disease using biomarkers; and Kantaro Biosciences LLC for developing and commercializing laboratory tests for the detection of antibodies against SARS-CoV-2. The company also has a partnership agreement with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to implement an advanced clinical care model designed to improve kidney health and reduce kidney disease progression and kidney failure in high-risk populations. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. Renalytix Plc was incorporated in 2018 and is headquartered in New York, New York. Address: 1460 Broadway, New York, NY, United States, 10036
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service